about
Ultrasound estimates of muscle quality in older adults: reliability and comparison of Photoshop and ImageJ for the grayscale analysis of muscle echogenicity.The Need for Standardized Assessment of Muscle Quality in Skeletal Muscle Function Deficit and Other Aging-Related Muscle Dysfunctions: A Symposium Report.Interrater reliability of quantitative ultrasound using force feedback among examiners with varied levels of experience.Diagnostic ultrasound estimates of muscle mass and muscle quality discriminate between women with and without sarcopenia.Intravenous immune globulin in hereditary inclusion body myopathy: a pilot studyAssessing function and endurance in adults with spinal and bulbar muscular atrophy: validity of the adult myopathy assessment tool.Disparities in the consequences of sarcopenia: implications for African American Veterans.Quantitative ultrasound: measurement considerations for the assessment of muscular dystrophy and sarcopenia.Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial.Defining Clinical Improvement in Adult and Juvenile Myositis.Reliability of the adult myopathy assessment tool in individuals with myositisLower extremity peak force and gait kinematics in individuals with inclusion body myositisProgressive Resistance Exercise with Eccentric Loading for the Management of Knee Osteoarthritis.Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis.Clinical Assessment of Fatigability in Multiple Sclerosis: A Shift from Perception to PerformanceEccentric Exercise Program Design: A Periodization Model for Rehabilitation Applications.Are repeated single-limb heel raises and manual muscle testing associated with peak plantar-flexor force in people with inclusion body myositis?Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.Sarcopenia and the New ICD-10-CM Code: Screening, Staging, and Diagnosis Considerations.Characterizing gait, locomotor status, and disease severity in children and adolescents with Friedreich ataxia.A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis.Physical Therapy Considerations for Chronic Kidney Disease and Secondary Sarcopenia.Using Xbox kinect motion capture technology to improve clinical rehabilitation outcomes for balance and cardiovascular health in an individual with chronic TBI.Intra-rater and inter-rater reliability of the 10-point Manual Muscle Test (MMT) of strength in children with juvenile idiopathic inflammatory myopathies (JIIM).The Comparative Associations of Ultrasound and Computed Tomography Estimates of Muscle Quality with Physical Performance and Metabolic Parameters in Older MenThe Influence of Upper and Lower Extremity Strength on Performance-Based Sarcopenia Assessment TestsEffects of virtual dance exercise on skeletal muscle architecture and function of community dwelling older womenMeasurements of temporal aspects of gait obtained with a multimemory stopwatch in persons with gait impairmentsPhysiotherapy management of patients with HIV-associated Kaposi's sarcomaAcute effects of static, dynamic, and proprioceptive neuromuscular facilitation stretching on muscle power in womenSafety and efficacy of submaximal eccentric strength training for a subject with polymyositisValidity of the single limb heel raise test to predict lower extremity disablement in patients with sporadic inclusion body myositisChronic kidney disease: considerations for monitoring skeletal muscle health and prescribing resistance exerciseAssociation Between Muscle Strength and Modeling Estimates of Muscle Tissue Heterogeneity in Young and Old Adults
P50
Q28364354-04AD83BA-DD93-45C9-AB0E-1BCB08D55853Q30235428-8FA89314-6022-4383-BCF8-2E6057588764Q30380656-B8342E97-AED3-4B5A-AF47-51681DC7CA9FQ30398718-10F052D7-9BE1-40B2-86AA-238EB14D1058Q33270749-78B4EB04-0585-4F16-9DA4-1EE20E2A38C7Q33634876-5117C87E-FC07-4FDD-B685-3BB3C35FC02DQ33850891-848D1478-C060-4A63-8989-357D3DF5DA1FQ33891261-3A4311C3-C860-4EDF-B7DB-9DF8421EA491Q34666168-BFCCCB0B-E074-4B99-B36B-3EA7F028CD17Q35074992-105A6B10-85CC-42D0-B0C0-F92F76924ECBQ35669132-F92B549A-FC17-4AA6-8B6A-48DBB71FFEE3Q35692602-269B8085-19BA-4EFB-B66F-1742ED205E3DQ35834891-415F2548-52AC-450D-81DD-AECCE2EE716FQ37201405-C87697D8-C26D-47AC-A58B-8A6C9E0BC947Q37397327-1984F3D5-C3F3-47C4-BDA7-A2AECA75D3A2Q37660821-9F5865F1-9DC0-4D3E-A345-A851DC5393FDQ37681219-18A9E5BA-239A-4FAF-BA95-43F563741394Q37704799-FAB7FAE9-4D4F-402E-A8AD-3FC2C7E16AAAQ41556895-37BC18B4-0D90-47FD-A5C2-36F999C5F642Q43266032-21034346-BA77-4720-A923-58893EE0F08FQ48549462-55D40996-ABCA-4C8C-8E33-052EB341A663Q51744730-2CED8F6C-61F8-4DC6-B5DC-AE8F34472176Q51804161-75699657-175C-4253-A34A-DF97BCF25B5FQ53009967-CD6F3DBD-9D03-42A0-BB07-6FA160A4F26CQ57478388-B6B11276-C183-47C0-A013-5E7408712872Q59807329-C62F5EF4-BB15-4AE6-8210-0DD5E7A9F08DQ64227145-B90FCD7E-86B0-4290-BE8F-26065DA0BAA8Q73806542-AF1D0412-97B9-4EF0-B027-8735657C66A8Q81573904-04F87684-8B03-45C6-A3AA-20D62094AE37Q81803814-D59ADE17-5F1E-4C8C-8E20-9412B65DCE43Q81811438-19D02894-91D3-467B-869C-0641F0D631DDQ87548268-9DDE0F1F-05E7-4E74-990C-1D7786F2CA37Q90325628-753F0687-8523-4A03-B127-29C2502D1E26Q90479700-93A90A76-2683-4548-A261-547567ECFFAF
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael Harris-Love
@ast
Michael Harris-Love
@en
Michael Harris-Love
@es
Michael Harris-Love
@nl
Michael Harris-Love
@sl
type
label
Michael Harris-Love
@ast
Michael Harris-Love
@en
Michael Harris-Love
@es
Michael Harris-Love
@nl
Michael Harris-Love
@sl
prefLabel
Michael Harris-Love
@ast
Michael Harris-Love
@en
Michael Harris-Love
@es
Michael Harris-Love
@nl
Michael Harris-Love
@sl
P106
P31
P496
0000-0002-1842-3269